跳至主要内容
临床试验/NCT00760032
NCT00760032撤回4 期

Association of Serum Levels of Lipopolysaccharide Binding Protein (LBP) With the Evolution of Pro- and Anti-inflammatory Cytokines, and the Development of Severe Infectious Events in Cirrhotic Patients

Florencia Vargas-Vorackova1 个研究点 分布在 1 个国家开始时间: 2008年9月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
发起方
试验地点
1
主要终点
Lipopolysaccharide binding protein plasma levels

研究概览

简要总结

The purpose of this study is to determine whether plasma levels of lipopolysaccharide binding protein (LBP) are correlated with PBMN pro- and anti-inflammatory cytokine secretion, as well as with the development of severe infectious events in cirrhotic patients with ascites. As a secondary purpose, the study will evaluate the effect of a prophylactic administration of ciprofloxacin on LBP, cytokines and infections in the same patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cirrhosis
  • No history of spontaneous bacterial peritonitis and/or < 1 g of protein in ascites
  • No antibiotic use in previous 6 weeks
  • Absence of infection (documented by clinical history, blood cytology, urinalysis and urine culture, thorax x-ray and paracentesis)
  • Absence of GI bleeding or encephalopathy
  • Signature of informed consent

排除标准

  • Ciprofloxacin contraindication
  • Autoimmune hepatitis, sclerosing cholangitis or other autoimmune disease
  • > 13 Child-Pugh points
  • Inability to attend to regular visits
  • Current alcohol intake
  • Terminal disease with < 24 week expected survival

研究组 & 干预措施

Active

Experimental

Ciprofloxacin

干预措施: Ciprofloxacin (Drug)

Placebo

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Lipopolysaccharide binding protein plasma levels

时间窗: 24 weeks

次要结局

  • Severe infection(24 weeks)
  • Pro- and anti-inflammatory cytokine secretion by PBMN cells(24 weeks)

研究者

发起方
Florencia Vargas-Vorackova
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Florencia Vargas-Vorackova

Doctor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

研究点 (1)

Loading locations...

相似试验

Lipopolysaccharide Binding Protein and Development... | 临床试验